Ketoconazole Foam 2% for the Treatment of Versicolor

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Ten adult patients age 19 and older with a clinical diagnosis of tinea versicolor, as well as a positive Potassium Hydroxide (KOH) using calcofluor. Ketoconazole 2% foam will be used to determine its effectiveness, safety and satisfaction when used to treat tinea versicolor.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Boni Elewski, MD
• Treatments: Ketoconazole

Criteria

Inclusion Criteria:

1. Male or female patients, aged 19 years and over.

2. Clinical presentation of tinea versicolor.

3. Positive KOH using calcofluor.

4. The ability to provide informed consent (including photography release)

Exclusion Criteria:

1. Use of topical antifungal to the affected area in the past 30 days

2. Use of topical steroid to the affected area in the past 14 days

3. If female, positive urine pregnancy test at screening (female patients of childbearing potential must be practicing a reliable method of birth control, not be planning a pregnancy, not be breast-feeding during the study)

4. Patients with a dermatologic condition in the region of the treatment site that in the investigator's opinion may interfere with the study results

5. Current diagnosis of immunocompromising conditions

6. Any medical or psychiatric condition that may interfere with treatment or compliance